C3.ai delivered $145.4 million in total revenue during the first half of its fiscal year 2026 (ended Oct. 31), which was down ...

C3.ai (NYSE:AI) was once hailed as a pioneer in enterprise AI software, but today grapples with a cascade of challenges that ...

Now that C3.ai has won a major government approval, will it finally be enough to coax hesitant investors toward its beaten-down shares?

A number of stocks fell in the afternoon session after concerns grew over lofty valuations and the uncertain profitability of ...

C3.ai stock drops after weak Q2 and FY26 outlook, but rising federal bookings signal recovery. Read here for an investment analysis of AI stock.

C3.ai's CEO Stephen Ehikian acknowledged the recent turmoil—from sales missteps to Tom Siebel's health-related leadership challenges.

Option traders moderately bearish in C3 AI (AI), with shares down 38c near $14.11. Options volume running well above average with 103k contracts ...

Shares of C3.ai (NYSE: AI) have witnessed a big sell-off this year, losing more than 55% of their value, as of this writing. This decline isn't surprising, as the company has fallen upon tough times ...

The department plans to use the company's agentic artificial intelligence to integrate disease-specific NIH data with ...

Enterprises running on Microsoft can now harness C3 AI’s production-proven intelligence layer for reasoning and automation at scale C3 AI (NYSE: AI), the Enterprise AI application software company, ...

Despite reporting solid revenue growth in Q3 2025, C3.ai stock has dropped approximately 35% over the past month, raising concerns of whether or not the drop was justified. One of the major strengths ...